Childhood cancer patients' access to cooperative group cancer programs - A population-based study

被引:115
作者
Liu, LH
Krailo, M
Reaman, GH
Bernstein, L
机构
[1] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[2] Childrens Oncol Grp, Ctr Stat, Arcadia, CA USA
[3] Childrens Natl Med Ctr, Dept Hematol & Oncol, Washington, DC 20010 USA
关键词
childhood cancer; clinical trials; cancer type; stage of disease; race/ethnicity; gender;
D O I
10.1002/cncr.11192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The Children's Oncology Group (COG), a merger of the Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG), conducts clinical trials for the treatment of childhood cancer. To assess the feasibility of developing a nationwide childhood cancer registry, the authors attempted to determine whether COG could serve as a resource for identifying all children with cancer. METHODS. A consolidated file of children age < 20 years who were diagnosed with cancer between 1992-1997 and registered with either CCG or POG was linked with records from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. Age-specific registration rates and age-adjusted registration rates (AARR) were calculated overall and by year of diagnosis, gender, race/ethnicity, stage of disease at diagnosis, and type of cancer. RESULTS. Of 10, 108 children age < 20 years with cancer who were identified by the 11 SEER registries between 1992-1997, 5796 were registered with CCG or POG. The AARR was 71% for children age < 15 years, 24% for adolescents ages 15-19 years, and 57% for children age < 20 years. Registration rates were stable over the years studied, varied by geographic region, and were found to be higher among children with more advanced disease. Registration rates were highest for children with leukemia, hepatic tumors, and renal tumors, and were lowest for carcinoma and retinoblastoma. CONCLUSIONS. The results of the current study demonstrate that not all children with cancer are registered by the cooperative groups; however, a national registry program can be achieved by supplementing cases identified through COG with data collected by statewide population-based cancer registries. Such a partnership would be mutually beneficial, allowing COG to achieve 100% registration of children with cancer and, for the statewide cancer registries, improving the timeliness of case-finding and follow-up information for cancer outcomes. (C) 2003 American Cancer Society.
引用
收藏
页码:1339 / 1345
页数:7
相关论文
共 14 条
[1]  
*AM CANC SOC, 2000, CANC FACTS FIG 2000
[2]  
BERNSTEIN L, 1993, CANCER-AM CANCER SOC, V71, P3222, DOI 10.1002/1097-0142(19930515)71:10+<3222::AID-CNCR2820711712>3.0.CO
[3]  
2-V
[4]  
CUSHMAN JH, 1997, NY TIMES A 0929, P1
[5]  
KRAILO MD, 1993, CANCER-AM CANCER SOC, V71, P3325, DOI 10.1002/1097-0142(19930515)71:10+<3325::AID-CNCR2820711731>3.0.CO
[6]  
2-K
[7]  
KRAMAROVA E, 1996, 29 IARC
[8]   INFLUENCE OF PLACE OF TREATMENT ON DIAGNOSIS, TREATMENT, AND SURVIVAL IN 3 PEDIATRIC SOLID TUMORS [J].
KRAMER, S ;
MEADOWS, AT ;
PASTORE, G ;
JARRETT, P ;
BRUCE, D .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (08) :917-923
[9]   SURVIVAL IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - EFFECT OF PROTOCOL AND PLACE OF TREATMENT [J].
MEADOWS, AT ;
KRAMER, S ;
HOPSON, R ;
LUSTBADER, E ;
JARRETT, P ;
EVANS, AE .
CANCER INVESTIGATION, 1983, 1 (01) :49-55
[10]  
*NIH, 1977, NIH PUB